multiple sclerosis
Generics Switching Program Saves Millions
A managed care outreach program that underscored the financial benefits of switching patients from branded to ...
MAY 29, 2024
People With MS Disproportionately at Risk for Hospitalization and Death From COVID-19
Even after receiving at least three COVID-19 vaccinations, people with MS had an almost six times greater risk for ...
APRIL 30, 2024
Multiple Sclerosis Generics Switching Program Saves Millions
A managed care pharmacist outreach program that converted 18% of patients on branded multiple sclerosis products to ...
APRIL 18, 2024
FDA Approves New Drug for Relapsing MS, But COVID-19 Delays Market Launch
The FDA has approved ozanimod 0.92 mg (Zeposia, Bristol-Myers Squibb) for the treatment of adults with relapsing ...
APRIL 1, 2020
FDA Approves New Oral Mavenclad for MS
Following the administration of two treatment courses, additional courses of cladribine are not to be administered ...
APRIL 1, 2019
FDA Approves Oral Drug for Relapsing Forms of MS
Mayzent is the first and only treatment specifically approved for patients with active secondary progressive ...
MARCH 27, 2019
Vitamin D3 May Benefit MS Patients
High doses of vitamin D3 may help regulate the hyperactive immune response in MS.
JANUARY 8, 2016
